Literature DB >> 22989110

Preoperative staging of locally advanced bladder cancer before radical cystectomy using 3 tesla magnetic resonance imaging with a standardized protocol.

Fredrik Liedberg1, Pär-Ola Bendahl, Thomas Davidsson, Sigurdur Gudjonsson, Magnus Holmer, Wiking Månsson, Nils-Olof Wallengren.   

Abstract

OBJECTIVE: The correlation between clinical tumour stage and pathological tumour stage in radical cystectomy specimens in locally advanced bladder cancer is suboptimal. Radiological methods have so far been of limited value in preoperative staging; however, the resolution with magnetic resonance imaging (MRI) has improved with further technical developments of the method. The aim of this study was to compare tumour stage at MRI with pathological tumour stage in the cystectomy specimen.
MATERIAL AND METHODS: Prospectively, 53 patients with invasive bladder cancer were preoperatively investigated with 3 tesla (3T) MRI using a standardized protocol. 3T MRI was performed at a standardized bladder volume. Clinical tumour stage, tumour stage at MRI and pathological tumour stage groups (Ta, Cis, T1/T2a, T2b/T3a, T3b/T4a), were compared, and sensitivity and specificity for organ-confined and non-organ-confined disease (stage T3a or above or lymph-node metastases) were analysed.
RESULTS: MRI overestimated tumour stage in 23 out of 47 patients (49%), whereas six patients (13%) were understaged. In the three groups of patients (those with the same stage group at MRI as in the cystectomy specimen, overestimated tumour stage and understaged patients), the time interval between transurethral resection of the bladder (TURB) and MRI did not differ significantly.
CONCLUSIONS: Preoperative MRI overestimated tumour stage in almost half of the patients investigated in this study. Postoperative changes could have contributed to such overstaging with MRI.

Entities:  

Mesh:

Year:  2012        PMID: 22989110     DOI: 10.3109/00365599.2012.721394

Source DB:  PubMed          Journal:  Scand J Urol        ISSN: 2168-1805            Impact factor:   1.612


  8 in total

Review 1.  Preoperative imaging for staging bladder cancer.

Authors:  Maxim J McKibben; Michael E Woods
Journal:  Curr Urol Rep       Date:  2015-04       Impact factor: 3.092

2.  Comparative sensitivity and specificity of imaging modalities in staging bladder cancer prior to radical cystectomy: a systematic review and meta-analysis.

Authors:  Jack Crozier; Nathan Papa; Marlon Perera; Brian Ngo; Damien Bolton; Shomik Sengupta; Nathan Lawrentschuk
Journal:  World J Urol       Date:  2018-08-17       Impact factor: 4.226

3.  Improving bladder cancer imaging using 3-T functional dynamic contrast-enhanced magnetic resonance imaging.

Authors:  Huyen T Nguyen; Kamal S Pohar; Guang Jia; Zarine K Shah; Amir Mortazavi; Debra L Zynger; Lai Wei; Daniel Clark; Xiangyu Yang; Michael V Knopp
Journal:  Invest Radiol       Date:  2014-06       Impact factor: 6.016

Review 4.  Current Concepts in the Management of Muscle Invasive Bladder Cancer.

Authors:  Suprita R Krishna; Badrinath R Konety
Journal:  Indian J Surg Oncol       Date:  2016-12-15

Review 5.  [Molecular multimodal hybrid imaging in prostate and bladder cancer].

Authors:  T Maurer; M Eiber; B J Krause
Journal:  Urologe A       Date:  2014-04       Impact factor: 0.639

6.  PET/CT versus conventional CT for detection of lymph node metastases in patients with locally advanced bladder cancer.

Authors:  Firas Aljabery; Gunnar Lindblom; Susann Skoog; Ivan Shabo; Hans Olsson; Johan Rosell; Staffan Jahnson
Journal:  BMC Urol       Date:  2015-08-21       Impact factor: 2.264

Review 7.  Evaluation of lymph node status in patients with urothelial carcinoma-still in search of the perfect imaging modality: a systematic review.

Authors:  Michał Frączek; Hubert Kamecki; Anna Kamecka; Roman Sosnowski; Katarzyna Sklinda; Marcin Czarniecki; Leszek Królicki; Jerzy Walecki
Journal:  Transl Androl Urol       Date:  2018-10

Review 8.  Current Staging Procedures in Urinary Bladder Cancer.

Authors:  Tobias Maurer; Thomas Horn; Matthias Heck; Jürgen E Gschwend; Matthias Eiber; Ambros J Beer
Journal:  Diagnostics (Basel)       Date:  2013-06-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.